Skip to main content

A Review of Pharmaceutical Company Contributions

Carol Adelman & Jeremiah Norris

To view this report, please click on the “View PDF” button below.

View PDF

Related Articles

Ukraine’s Odious Debts

Irwin M. Stelzer

It is a decade since America confronted the question of just how much financial assistance to provide Iraq, then burdened with billions in debt incurr...

Continue Reading

The FDA Nixes a Pathbreaking Drug for MS

Christopher DeMuth & Christopher DeMuth Jr.

Under the brand name Lemtrada (a product of Sanofi and its U.S. subsidiary Genzyme), the drug has been approved in recent months for treating MS in ...

Continue Reading

Re-Imagining the Doctor

Ronald W. Dworkin

The physician has long held a place of high regard in the American imagination. In our most idealized picture, the doctor is a well-trained, beneficen...

View PDF